Literature DB >> 25792278

Soluble interleukin 6 receptor levels are associated with reduced myocardial reperfusion after percutaneous coronary intervention for acute myocardial infarction.

Hilde E Groot1, Minke H T Hartman1, Youlan L Gu1, Bart J G L de Smet2, Ad F M van den Heuvel1, Erik Lipsic1, Pim van der Harst3.   

Abstract

AIMS: Interleukin-6 receptor (IL-6R) signalling has been suggested to play a causal role in the development and outcome of coronary heart disease (CHD). The aim of this study was to investigate the association of sIL-6R levels with myocardial reperfusion after percutaneous coronary intervention (PCI) for acute ST-elevated myocardial infarction (STEMI).
METHODS: Blood was sampled from 70 patients presenting with STEMI at 6 different time-points (baseline, post-PCI, t=1h, t=6h, t=24h, t=2w). Coronary angiograms post-PCI were analysed for myocardial blush grade (MBG) as indicator of myocardial reperfusion. Serum IL-6 and sIL-6R were measured using IL-6 and sIL-6R enzyme-linked immunosorbent assays (ELISA).
RESULTS: sIL-6R levels fluctuated biphasic during the two weeks after STEMI. Reduced MBG was associated with a larger change in sIL-6R levels between baseline and post-PCI compared to optimal MBG (-13.40; SEM 2.78ng/ml vs -1.99; SEM 2.35ng/ml, respectively; p<0.001). Patients with reduced MBG also showed a larger increase in sIL-6R levels after PCI and 1h after myocardial infarction (MI) compared to optimal MBG (respectively 11.56; SEM 2.68ng/ml vs 3.02; SEM 2.39ng/ml; p=0.018). IL-6/sIL-6R ratio was also more increased in patients with reduced MBG at 24h after myocardial infarction (0.23; SEM 0.08-0.51 vs 0.10; SEM 0.05-0.21; p=0.024). An optimal MBG was associated with a 10ng increase in sIL-6R level between baseline and post-PCI (OR 1.687, CI 1.095-2.598; p=0.018).
CONCLUSIONS: sIL-6R levels fluctuate biphasic during the two weeks after MI with larger changes and increased IL-6/sIL-6R ratio in patients with reduced MBG. Further research is needed to increase our understanding of the possible causality of these associations.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Myocardial reperfusion; Soluble interleukin-6 receptor

Mesh:

Substances:

Year:  2015        PMID: 25792278     DOI: 10.1016/j.cyto.2015.02.004

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  8 in total

1.  Association between interleukin-6 and the risk of cardiac events measured by coronary computed tomography angiography.

Authors:  Lei Zhao; Xilin Wang; Yuhai Yang
Journal:  Int J Cardiovasc Imaging       Date:  2017-02-24       Impact factor: 2.357

2.  Circulating Levels of IL-6 Receptor and gp130 and Long-Term Clinical Outcomes in ST-Elevation Myocardial Infarction.

Authors:  Vibeke N Ritschel; Ingebjørg Seljeflot; Harald Arnesen; Sigrun Halvorsen; Jan Eritsland; Morten W Fagerland; Geir Ø Andersen
Journal:  J Am Heart Assoc       Date:  2016-06-13       Impact factor: 5.501

3.  Total flavonoid extract from Coreopsis tinctoria Nutt. protects rats against myocardial ischemia/reperfusion injury.

Authors:  Ya Zhang; Changsheng Yuan; He Fang; Jia Li; Shanshan Su; Wen Chen
Journal:  Iran J Basic Med Sci       Date:  2016-09       Impact factor: 2.699

4.  Elevated serum FGF21 predicts the major adverse cardiovascular events in STEMI patients after emergency percutaneous coronary intervention.

Authors:  Lingyun Gu; Wenlong Jiang; Huidong Qian; Ruolong Zheng; Weizhang Li
Journal:  PeerJ       Date:  2021-09-30       Impact factor: 2.984

5.  Interleukin 6 trans-signalling and the risk of future cardiovascular events in men and women.

Authors:  Yasmin Miri; Karin Leander; Per Eriksson; Bruna Gigante; Louise Ziegler
Journal:  Open Heart       Date:  2021-10

6.  Resveratrol improves cardiac function and left ventricular fibrosis after myocardial infarction in rats by inhibiting NLRP3 inflammasome activity and the TGF-β1/SMAD2 signaling pathway.

Authors:  Jinjin Jiang; Xiuping Gu; Huifeng Wang; Shibin Ding
Journal:  PeerJ       Date:  2021-05-28       Impact factor: 2.984

7.  Ex vivo Ikkβ ablation rescues the immunopotency of mesenchymal stromal cells from diabetics with advanced atherosclerosis.

Authors:  Ozge Kizilay Mancini; David N Huynh; Liliane Menard; Dominique Shum-Tim; Huy Ong; Sylvie Marleau; Ines Colmegna; Marc J Servant
Journal:  Cardiovasc Res       Date:  2021-02-22       Impact factor: 10.787

8.  IL6 trans-signaling associates with ischemic stroke but not with atrial fibrillation.

Authors:  Louise Ziegler; Håkan Wallén; Sara Aspberg; Ulf de Faire; Bruna Gigante
Journal:  BMC Neurol       Date:  2021-08-09       Impact factor: 2.903

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.